|
MENTOR TEXAS MENTOR MEMORYSHAPE BREAST IMPLANT; PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED
|
Back to Search Results |
|
| Catalog Number |
3341155 |
| Medical Device Problem Code |
Material Rupture (1546)
|
| Health Effect - Clinical Codes |
Deformity/ Disfigurement (2360); Wrinkling (2613); Breast Discomfort/Pain (4504); No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
11/20/2024
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
It was reported that a patient with mentor memoryshape breast implants experienced rupture on the left side post-operatively, which was confirmed via mammogram.As a result, the patient is scheduled for removal on (b)(6) 2025.
|
| |
|
Additional Manufacturer Narrative
|
|
Since the device has not been returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors can be made.As such, the investigation will be closed.If the complaint device is received in the future, the investigation will be reopened and conducted as appropriate.A manufacturing record evaluation (mre) was performed, and no anomalies were found related to this complaint.In addition, the mre verifies that the device was manufactured in accordance with documented specification and procedures.Mentor is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which mentor has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, mentor, or its employees that the report constitutes an admission that the device, mentor, or its employees caused or contributed to the potential event described in this report.If certain information is unknown, not available or does not apply, the section/field of the form is left blank.Reason for device explant and/or reoperation: rupture.Manufacturer¿s reference number: (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
On jan 7, 2026, additional information was received indicating the explantation surgery has been rescheduled to (b)(6) 2026.The replacement devices were identified as non-mentor breast implants.Manufacturer¿s reference number: (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
On feb 10, 2026, additional information was received indicating the replacement devices were non-mentor breast implants.The patient also reportedly experienced breast pain, rippling, and implant site fluid collection on the left side.The date of event was identified as nov 20, 2024.On mar 6, 2026, the mentor failure analysis lab received the device for evaluation.The analysis has begun, but is not complete at this time.When the investigational analysis has been completed, a supplemental report will be submitted.Manufacturer¿s reference number: (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
On april 5, 2026, mentor completed evaluation of the device.Device evaluation summary: the product was returned to mentor for evaluation.Mentor conducted a visual inspection and microscopic examination of the returned device.Visual analysis of the returned device revealed that the breast implant was found to be ruptured.Microscopic examination was performed on the edges of the rupture, and parallel striations were found in an area of the tear on the anterior view, measuring approximately 0.2 cm.Parallel striations are consistent with markings made by a sharp object perforating the implant shell.The cause of the rupture in the remaining area of the tear could not be identified.Mentor also performed a manufacturing record evaluation related to the reported complaint for the finished device lot number.No manufacturing non-conformances were identified as part of this evaluation.Most women undergoing augmentation or reconstruction with a mammary prosthesis will experience some pain postoperatively.While pain normally subsides in most women as they heal from surgery, it can become a chronic problem in other women.Chronic pain can be associated with a variety of factors.Surgeons should instruct their patients to inform them if there is significant pain or if pain persists.Pain is a known complication associated with these devices and is referenced in our current product insert data sheet.As part of mentor's quality process, all devices are manufactured, inspected, and released according to approved specifications.Based on the results of this investigation, it was determined that the product met the manufacturing release criteria: no corrective and preventive action (capa) is required now.Additional complaint information monitoring for potential safety signals is conducted through complaint trending as part of post market surveillance.Manufacturer¿s reference number: (b)(4).
|
| |
|
Search Alerts/Recalls
|
|
|